Congenital toxoplasmosis: prevention, screening and treatment

Journal of Hospital Infection

Volumn 30, Issue SUPPL., 1995, Pages 179-190

  Holliman, R E ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Congenital toxoplasmosis; prevention; screening; treatment

Indexed keywords

PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN;

ABORTION; CONFERENCE PAPER; CONGENITAL TOXOPLASMOSIS; EYE DISEASE; FEMALE; HEALTH EDUCATION; HUMAN; IMMUNIZATION; NEWBORN; PATIENT COUNSELING; RISK BENEFIT ANALYSIS; SCREENING;

FEMALE; HEALTH EDUCATION; HUMAN; INFANT, NEWBORN; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 0029058818     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/0195-6701(95)90018-7     Document Type: Article

References (45)

1. Toxoplasmosis
2. Screening programme for congenital toxoplasmosis in France
3. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria
4. Screening for toxoplasma in pregnancy
5. Toxoplasmosis: the time has come
6. Congenital toxoplasmosis
7. Toxoplasmosis in pregnancy and its transmission to the foetus
8. Clinical sequelae of chronic maternal toxoplasmosis
9. Epidemiology of toxoplasmosis in the UK
10. Longitudinal study of toxoplasma seroprevalence in South Yorkshire
11. Screening for toxoplasmosis during pregnancy
12. Results of 20 year follow-up of congenital toxoplasmosis
13. Congenital toxoplasmosis. A long-term follow-up of 20 years
14. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection
15. Efforts towards a vaccine against Toxoplasma gondii: a review
16. Vaccination of sheep with a live, incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant
17. What is known about the prevention of congenital toxoplasmosis?
18. Breaking the transmission chain of toxoplasma: a program for the prevention of human toxoplasmosis
19. The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis
20. Congenital toxoplasmosis—why and how to screen
21. Prophylaxie des toxoplasmoses du nouveau né et de la femme enceinte
22. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis
23. Fetal blood sampling in retreat
24. Difficulties in the diagnosis of congenital toxoplasmosis by cordocentesis. Case report
25. Evaluating the sensitivity and predictive value of tests of recent infection toxoplasmosis in pregnancy
26. Scand J Infect Dis
27. Neonatal screening for congenital toxoplasmosis in Denmark: Presentation of the design of a prospective study
28. Medical audit of the investigation of toxoplasmosis associated with pregnancy
29. Rappel de l'importance du suivi sérologique des enfants suspects de toxoplasmose congénitale
30. Uncommon infections: 4. Toxoplasmosis, toxocariasis and cryptosporidiosis
31. Treatment of toxoplasmosis in the pregnant mother and newborn child
32. Prophylaxis of congenital toxoplasmosis Effects of spiramycin on placental infection
33. Foetopathie toxoplasmique. Traitaient in utero par l'association pyriméthamine-sulfamides
34. Fetal toxoplasmosis: Outcome of pregnancy and infant follow up after in utero treatment
35. Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis
36. Principles and Practice of Screening For Disease
37. Psychological costs of screening
38. Screening for toxoplasmosis during pregnancy
39. The evaluation of new services: Possibilities for preventing congenital toxoplasmosis
40. Congenital toxoplasmosis: to screen or not to screen?
41. Preventing congenital toxoplasmosis
42. Screening, ethics and the law
43. Controversy in the detection of disease